Welcome to our dedicated page for HYPERFINE SEC filings (Ticker: HYPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Regulatory language around bedside MRI, FDA clearances, and subscription revenue can turn Hyperfine’s SEC reports into a maze. If you have ever typed “Hyperfine SEC filings explained simply� or wondered how Swoop’s hospital adoption shows up in a 10-K, this page was built for you. Stock Titan’s AI reads each disclosure the moment it hits EDGAR and surfaces what matters—device margin trends, service renewal rates, and clinical trial updates—in plain English.
Need to track “Hyperfine quarterly earnings report 10-Q filing� without digging through footnotes? Our real-time engine highlights segment revenue, R&D burn, and cash runway the second the document drops. Curious about management confidence? Receive instant alerts on “Hyperfine insider trading Form 4 transactions� and monitor “Hyperfine Form 4 insider transactions real-time� as executives buy or sell shares. The platform also connects dots across releases, turning every “Hyperfine 8-K material events explained� into a concise timeline.
For a deeper dive, open the “Hyperfine annual report 10-K simplified� to see FDA-related risk factors and subscription retention metrics distilled into quick-read summaries. Compare board pay in the “Hyperfine proxy statement executive compensation� or study capital allocation moves inside each “Hyperfine earnings report filing analysis.� From “understanding Hyperfine SEC documents with AI� to spotting “Hyperfine executive stock transactions Form 4,� our coverage spans all filings�10-K, 10-Q, 8-K, S-1, and more—updated in real time, explained in everyday language, and ready to guide your next investment decision.
Hyperfine, Inc. (HYPR) reporting person Thomas Teisseyre, Chief Operating Officer and Director, reported a sale of Class A common stock on 08/18/2025. The Form 4 shows 1,151 shares were sold at $1.33 per share to satisfy tax withholding obligations tied to restricted stock units granted on March 28, 2022 and April 28, 2022. After the reported sale, Mr. Teisseyre beneficially owned 381,062 shares. The sale was executed under a "sell to cover" provision in the RSU agreement and the form was signed by an attorney-in-fact.
Hyperfine, Inc. furnished a press release announcing results for the second quarter ended June 30, 2025 and provided a business update; the press release is attached as Exhibit 99.1 to this Form 8-K.
The filing states the furnished material is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference. The company lists its Class A common stock (HYPR) on The Nasdaq Stock Market and indicates it is an emerging growth company. The report is signed by Brett Hale in his capacities as Chief Administrative Officer and Chief Financial Officer.
Hyperfine, Inc. (HYPR) received a Nasdaq notice on April 30, 2025 that its closing bid price fell below the $1.00 minimum for 30 consecutive business days and therefore did not meet Nasdaq Listing Rule 5450(a)(1). On August 6, 2025, Nasdaq notified the Company that it has regained compliance with the bid-price requirement and the matter is closed.
Key facts:
- Nasdaq deficiency notice: April 30, 2025
- Regained compliance and matter closed: August 6, 2025
- Ticker: HYPR; security: Class A common stock on the Nasdaq Global Market
FAQ
What is the current stock price of HYPERFINE (HYPR)?
What is the market cap of HYPERFINE (HYPR)?
